Absci Corp (ABSI) - Total Liabilities
Based on the latest financial reports, Absci Corp (ABSI) has total liabilities worth $34.65 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Absci Corp cash conversion from operations to assess how effectively this company generates cash.
Absci Corp - Total Liabilities Trend (2019–2024)
This chart illustrates how Absci Corp's total liabilities have evolved over time, based on quarterly financial data. Check Absci Corp (ABSI) asset resilience to evaluate the company's liquid asset resilience ratio.
Absci Corp Competitors by Total Liabilities
The table below lists competitors of Absci Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Oxiquim S.A
SN:OXIQUIM
|
Chile | CL$118.48 Billion |
|
Infortrend Technology Inc
TW:2495
|
Taiwan | NT$2.62 Billion |
|
Alucon Public Company Limited
BK:ALUCON
|
Thailand | ฿964.96 Million |
|
Dimerco Express
TWO:5609
|
Taiwan | NT$3.60 Billion |
|
RFG Holdings Ltd
JSE:RFG
|
South Africa | ZAC2.14 Billion |
|
Baiyang Aquatic Group Inc
SHE:002696
|
China | CN¥2.19 Billion |
|
Invercap
SN:INVERCAP
|
Chile | CL$3.40 Billion |
|
Bus Online Co Ltd
SHE:002188
|
China | CN¥196.63 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Absci Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ABSI market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Absci Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Absci Corp (2019–2024)
The table below shows the annual total liabilities of Absci Corp from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $34.48 Million | -16.16% |
| 2023-12-31 | $41.12 Million | -11.74% |
| 2022-12-31 | $46.59 Million | -22.46% |
| 2021-12-31 | $60.09 Million | +178.65% |
| 2020-12-31 | $21.56 Million | -64.43% |
| 2019-12-31 | $60.63 Million | -- |
About Absci Corp
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treat… Read more